The tiredness that follows lymphoma treatment is not ordinary tiredness and does not reliably improve with rest. Several of its causes, including anaemia, an underactive thyroid, poor sleep and low mood, are separate and separately treatable, which is the reason to report it rather than to absorb it.
What it is. Lymphoma Action describes cancer-related fatigue as a type of extreme tiredness that can be physical, mental and emotional, at a much higher level than would usually be expected, and says it can also happen months or years after treatment as a late effect. Macmillan says people with cancer may feel exhausted even if they are getting enough rest and sleep, that for most people fatigue gets better after treatment finishes, and that for some it may continue for months or sometimes years.
Why it is worth taking apart. Several contributors to it have their own treatment. Anaemia is one, and is found on a full blood count. An underactive thyroid is another, and after radiotherapy to the neck Lymphoma Action says a blood test is done once a year to check for it; the charity notes that the risk of an underactive thyroid is highest in the first five years after treatment and stays higher than it would otherwise have been after that. Lung scarring after chest radiotherapy, bleomycin or rituximab can present as breathlessness on exertion rather than as tiredness. Low mood and poor sleep are treatable in their own right. Pursuing the list is more useful than being told to pace yourself.
What helps. Lymphoma Action's exercise material and the general cancer literature both put graded physical activity ahead of rest; the charity publishes practical material on planning activities around energy levels and on coping with fatigue. Macmillan's tiredness page describes the same approach for any cancer.
The honest part. For some people the fatigue lasts a long time, and a person can be in complete remission and still unable to work a full week. Lymphoma Action's recovery material treats this as a recognised part of recovery rather than as a failure to bounce back, and its fatigue page says that for many people it gets better over time while for some the effects last much longer.
Showing the technology this term belongs to: Cognitive behavioural therapy for fatigue and distress.
Shares Relapsed and refractory classical Hodgkin lymphoma, Early-stage classical Hodgkin lymphoma (stage I to II), Advanced-stage classical Hodgkin lymphoma (stage III to IV), Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).
Shares Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome), Waldenström macroglobulinaemia, Marginal zone lymphoma, Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma).
Shares Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome), Waldenström macroglobulinaemia, Marginal zone lymphoma, Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma).
Shares Early-stage classical Hodgkin lymphoma (stage I to II), Advanced-stage classical Hodgkin lymphoma (stage III to IV), Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma), Late effects and survivorship toxicity.
Shares Waldenström macroglobulinaemia, Marginal zone lymphoma, Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma), Mantle cell lymphoma.
Shares Relapsed and refractory classical Hodgkin lymphoma, Early-stage classical Hodgkin lymphoma (stage I to II), Advanced-stage classical Hodgkin lymphoma (stage III to IV), Waldenström macroglobulinaemia.
Shares Waldenström macroglobulinaemia, Marginal zone lymphoma, Survivorship care and late-effects surveillance, Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma).
Shares Waldenström macroglobulinaemia, Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma), Mantle cell lymphoma, Follicular lymphoma.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/